| 000 | 03209nam a22005175i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-25752-5 | ||
| 003 | DE-He213 | ||
| 005 | 20250710083934.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2005 xxu| s |||| 0|eng d | ||
| 020 |
_a9780387257525 _a99780387257525 |
||
| 024 | 7 |
_a10.1007/b135898 _2doi |
|
| 082 | 0 | 4 |
_a338.9 _223 |
| 100 | 1 |
_aHyman, David. _eeditor. |
|
| 245 | 1 | 0 |
_aImproving Healthcare _h[recurso electrónico] : _bA Dose of Competition A Report By The Federal Trade Commission and Department of Justice (July, 2004), with various Supplementary Materials / _cedited by David Hyman. |
| 246 | 3 | _aReport By The Federal Trade Commission and Department of Justice (July, 2004), with various Supplementary Materials | |
| 264 | 1 |
_aBoston, MA : _bSpringer US, _c2005. |
|
| 300 |
_aXV, 430 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_arecurso en línea _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aDevelopments in Health Economics and Public Policy, _x0927-4987 ; _v9 |
|
| 505 | 0 | _aExecutive Summary -- Overview/Background -- Industry Snapshot and Competition Law: Physicians -- Industry Snapshot: Hospitals -- Competition Law: Hospitals -- Industry Snapshot: Insurance and Other Third Party Payment Programs -- 6: Competition Law: Insurers -- Industry Snapshot and Competition Law: Pharmaceuticals -- Miscellaneous Subjects. | |
| 520 | _aImproving Healthcare: A Dose of Competition systematically examines the American health care system from a competition-oriented perspective. The volume surveys the performance of each major sector of the health care system, and identifies impediments to more effective competition. Improving Healthcare examines such issues as competition v. regulation, public and private sector approaches to health care financing, cross-subsidies, licensure, provider market concentration, financial and clinical integration, payment for performance, quality, pharmacy benefit managers, direct-to-consumer advertising of pharmaceuticals, certificates of need, mandates, unionization, the significance of organizational status (nonprofit v. for-profit), and the role of antitrust and consumer protection in health care. It offers concrete recommendations to improve the quality and cost-effectiveness of the American health care marketplace. | ||
| 650 | 0 | _aECONOMICS. | |
| 650 | 0 |
_aMEDICAL RECORDS _xDATA PROCESSING. |
|
| 650 | 0 | _aPUBLIC HEALTH LAWS. | |
| 650 | 0 | _aECONOMIC POLICY. | |
| 650 | 0 | _aSOCIAL POLICY. | |
| 650 | 0 | _aCOMMERCIAL LAW. | |
| 650 | 1 | 4 | _aECONOMICS/MANAGEMENT SCIENCE. |
| 650 | 2 | 4 | _aECONOMIC POLICY. |
| 650 | 2 | 4 | _aLAW AND ECONOMICS. |
| 650 | 2 | 4 | _aMEDICAL LAW. |
| 650 | 2 | 4 | _aHEALTH INFORMATICS. |
| 650 | 2 | 4 | _aSOCIAL POLICY. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9780387257518 |
| 830 | 0 |
_aDevelopments in Health Economics and Public Policy, _x0927-4987 ; _v9 |
|
| 856 | 4 | 0 |
_uhttp://dx.doi.org/10.1007/b135898 _zVer el texto completo en las instalaciones del CICY |
| 912 | _aZDB-2-SBE | ||
| 942 |
_2ddc _cER |
||
| 999 |
_c56477 _d56477 |
||